BridgeBio is substantially boosted the development of a innovative treatment for amyloid heart disease, employing Attruby. Preliminary patient results reveals promising benefits for patients diagnosed by the severe https://biotech386354.bluxeblog.com/74606445/company-progresses-amyloidosis-therapy-with-the-therapy